BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 10975847)

  • 1. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin.
    Lee RS; Tartour E; van der Bruggen P; Vantomme V; Joyeux I; Goud B; Fridman WH; Johannes L
    Eur J Immunol; 1998 Sep; 28(9):2726-37. PubMed ID: 9754560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAP-independent presentation of CTL epitopes by Trojan antigens.
    Lu J; Wettstein PJ; Higashimoto Y; Appella E; Celis E
    J Immunol; 2001 Jun; 166(12):7063-71. PubMed ID: 11390450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
    Chikh GG; Kong S; Bally MB; Meunier JC; Schutze-Redelmeier MP
    J Immunol; 2001 Dec; 167(11):6462-70. PubMed ID: 11714813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
    Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
    Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.
    Brossart P; Bevan MJ
    Blood; 1997 Aug; 90(4):1594-9. PubMed ID: 9269778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
    Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
    Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants.
    Simmons CP; Mastroeni P; Fowler R; Ghaem-maghami M; Lycke N; Pizza M; Rappuoli R; Dougan G
    J Immunol; 1999 Dec; 163(12):6502-10. PubMed ID: 10586042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
    Rice J; Buchan S; Stevenson FK
    J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.
    Luft T; Rizkalla M; Tai TY; Chen Q; MacFarlan RI; Davis ID; Maraskovsky E; Cebon J
    J Immunol; 2001 Sep; 167(5):2529-37. PubMed ID: 11509592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization.
    Haicheur N; Benchetrit F; Amessou M; Leclerc C; Falguières T; Fayolle C; Bismuth E; Fridman WH; Johannes L; Tartour E
    Int Immunol; 2003 Oct; 15(10):1161-71. PubMed ID: 13679386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway.
    Morón VG; Rueda P; Sedlik C; Leclerc C
    J Immunol; 2003 Sep; 171(5):2242-50. PubMed ID: 12928368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
    Levitt JM; Howell DD; Rodgers JR; Rich RR
    Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells.
    Stober D; Trobonjaca Z; Reimann J; Schirmbeck R
    Eur J Immunol; 2002 Apr; 32(4):1099-108. PubMed ID: 11920577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
    Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
    J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
    Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
    Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.